This topic contains a solution. Click here to go to the answer

Author Question: High barriers to entry protect the market power of existing firms and discourage the formation of ... (Read 110 times)

Yolanda

  • Hero Member
  • *****
  • Posts: 757
High barriers to entry protect the market power of existing firms and discourage the formation of firms which:
 a. invest heavily in research and development activities.
  b. use illegal procedures to capture the market.
  c. are inefficiently small and cannot realize economies of scale.
  d. are large enough to dominate the existing firms.

Question 2

A monopolist's supply curve cannot be derived directly from its marginal cost curve as in the case of a competitive firm.
 a. True
  b. False
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

durant1234

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

C

Answer to Question 2

True




Yolanda

  • Member
  • Posts: 757
Reply 2 on: Jun 30, 2018
Gracias!


apple

  • Member
  • Posts: 352
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Cyanide works by making the human body unable to use oxygen.

Did you know?

GI conditions that will keep you out of the U.S. armed services include ulcers, varices, fistulas, esophagitis, gastritis, congenital abnormalities, inflammatory bowel disease, enteritis, colitis, proctitis, duodenal diverticula, malabsorption syndromes, hepatitis, cirrhosis, cysts, abscesses, pancreatitis, polyps, certain hemorrhoids, splenomegaly, hernias, recent abdominal surgery, GI bypass or stomach stapling, and artificial GI openings.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library